+426.4%
MRNA vs CHYM
-23.3%
+449.7%
-35.5%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | CHYM | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | +1.0% | +4.4% | +5.1% |
| 7D | -1.1% | -2.3% | +1.2% | -0.6% |
| 30D | +126.1% | +4.4% | +121.7% | +125.0% |
| 3M | +190.0% | +91.3% | +98.7% | +156.7% |
| 6M | +157.2% | +44.0% | +113.2% | +136.1% |
| YTD | +388.2% | +31.1% | +357.1% | +348.2% |
| 1Y | +467.0% | +37.8% | +429.2% | +419.4% |
| All | +426.4% | -23.3% | +449.7% | +387.8% |
Cumulative growth
Daily Returns
Daily percentage return beside CHYM.
Daily Out/Under-Performance
Portfolio return minus CHYM return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CHYM return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded CHYM wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling